Fractyl Health (GUTS) Change in Cash (2023 - 2026)
Fractyl Health (GUTS) reported Change in Cash of -$18.4 million for Q1 2026, up 27.54% year-on-year from -$14.4 million in Q1 2025, and down 573.14% quarter-over-quarter from $3.9 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Change in Cash data on file, last reported at -$18.4 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 27.54% year-over-year to -$18.4 million; the trailing twelve-month figure through Mar 2026 stood at $21.1 million (up 126.44% YoY), and the FY2025 full-year result was $14.1 million, down 58.53% from the prior year.
- Change in Cash for Q1 2026 stood at -$18.4 million, down from $3.9 million in the prior quarter.
- Across five years, Change in Cash topped out at $88.2 million in Q1 2024 and bottomed at -$25.4 million in Q1 2025.
- A 4-year average of $1.1 million and a median of -$11.7 million in 2023 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 1021.77% in 2024, while the deepest fall reached 207.67% in 2024.
- Tracing GUTS's Change in Cash over 4 years: stood at -$11.3 million in 2023, then slumped by 52.33% to -$17.2 million in 2024, then surged by 122.58% to $3.9 million in 2025, then sank by 573.14% to -$18.4 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$18.4 million, $3.9 million, and $55.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | -153.10 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | -18.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.37 Mn |
| Dec 31, 2025 | 3.88 Mn |
| Sep 30, 2025 | 55.37 Mn |
| Jun 30, 2025 | -19.82 Mn |
| Mar 31, 2025 | -25.36 Mn |
| Dec 31, 2024 | -17.20 Mn |
| Sep 30, 2024 | -18.09 Mn |
| Jun 30, 2024 | -19.00 Mn |
| Mar 31, 2024 | 88.23 Mn |
| Dec 31, 2023 | -11.29 Mn |
| Sep 30, 2023 | 16.80 Mn |
| Jun 30, 2023 | -11.68 Mn |
| Mar 31, 2023 | -9.57 Mn |